Disease-association analysis of an inflammation-related feedback loop

Cell Reports

Volumn 3, Issue 3, 2013, Pages 946-959

  Murakami, Masaaki ^a   Harada, Masaya ^a   Kamimura, Daisuke ^a   Ogura, Hideki ^a   Okuyama, Yuko ^a   Kumai, Noriko ^a   Okuyama, Azusa ^a   Singh, Rajeev ^a   Jiang, Jing Jing ^a   Atsumi, Toru ^a   Shiraya, Sayaka ^a   Nakatsuji, Yuji ^b   Kinoshita, Makoto ^b   Kohsaka, Hitoshi ^c   Nishida, Makoto ^b   Sakoda, Saburo ^d   Miyasaka, Nobuyuki ^c   Yamaguchi Takihara, Keiko ^b   Hirano, Toshio ^b  

^a JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d TONEYAMA NATIONAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIREGULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; STAT3 PROTEIN;

ARTICLE; AUTOIMMUNE DISEASE; DISEASE ASSOCIATION; DISEASE MODEL; FEEDBACK SYSTEM; GENE IDENTIFICATION; HUMAN; IN VITRO STUDY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ARTHRITIS, RHEUMATOID; CELL LINE; EPIDERMAL GROWTH FACTOR; EPISTASIS, GENETIC; FEEDBACK, PHYSIOLOGICAL; GENES, ERBB-1; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENOME; HUMANS; INFLAMMATION; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

ANIMALIA; MUS;

EID: 84875814613     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.01.028     Document Type: Article

References (47)

1. Adachi Y., Aoki C., Yoshio-Hoshino N., Takayama K., Curiel D.T., Nishimoto N. Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas. Int. J. Cancer 2006, 119:1303-1311.
2. Afzali B., Lombardi G., Lechler R.I., Lord G.M. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin. Exp. Immunol. 2007, 148:32-46.
3. Arima Y., Harada M., Kamimura D., Park J.-H., Kawano F., Yull F.E., Kawamoto T., Iwakura Y., Betz U.A., Márquez G., et al. Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Cell 2012, 148:447-457.
4. Atsumi T., Ishihara K., Kamimura D., Ikushima H., Ohtani T., Hirota S., Kobayashi H., Park S.J., Saeki Y., Kitamura Y., Hirano T. A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit gp130 causes autoimmune arthritis. J. Exp. Med. 2002, 196:979-990.
5. Awasthi A., Kuchroo V.K. Th17 cells: from precursors to players in inflammation and infection. Int. Immunol. 2009, 21:489-498.
6. Bertram L., Lill C.M., Tanzi R.E. The genetics of Alzheimer disease: back to the future. Neuron 2010, 68:270-281.
7. Bettelli E., Oukka M., Kuchroo V.K. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 2007, 8:345-350.
8. Consortium T.W.T.C.C. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678. Wellcome Trust Case Control Consortium.
9. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003, 421:744-748.
10. D'Acquisto F., Iuvone T., Rombolà L., Sautebin L., Di Rosa M., Carnuccio R. Involvement of NF-kappaB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS Lett. 1997, 418:175-178.
11. Ferrand A., Kowalski-Chauvel A., Bertrand C., Escrieut C., Mathieu A., Portolan G., Pradayrol L., Fourmy D., Dufresne M., Seva C. A novel mechanism for JAK2 activation by a G protein-coupled receptor, the CCK2R: implication of this signaling pathway in pancreatic tumor models. J. Biol. Chem. 2005, 280:10710-10715.
12. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., Weaver C.T. Interleukin 17-producing CD4++ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123-1132.
13. Hemminki K., Försti A., Houlston R., Bermejo J.L. Searching for the missing heritability of complex diseases. Hum. Mutat. 2011, 32:259-262.
14. Hirano T. Interleukin 6 and its receptor: ten years later. Int. Rev. Immunol. 1998, 16:249-284.
15. Hirano T. Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2010, 86:717-730.
16. Hirota K., Hashimoto M., Yoshitomi H., Tanaka S., Nomura T., Yamaguchi T., Iwakura Y., Sakaguchi N., Sakaguchi S. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17++ Th cells that cause autoimmune arthritis. J. Exp. Med. 2007, 204:41-47.
17. Igarashi H., Hashimoto J., Tomita T., Yoshikawa H., Ishihara K. TP53 mutations coincide with the ectopic expression of activation-induced cytidine deaminase in the fibroblast-like synoviocytes derived from a fraction of patients with rheumatoid arthritis. Clin. Exp. Immunol. 2010, 161:71-80.
18. Ishihara K., Sawa S., Ikushima H., Hirota S., Atsumi T., Kamimura D., Park S.J., Murakami M., Kitamura Y., Iwakura Y., Hirano T. The point mutation of tyrosine 759 of the IL-6 family cytokine receptor gp130 synergizes with HTLV-1 pX in promoting rheumatoid arthritis-like arthritis. Int. Immunol. 2004, 16:455-465.
19. Iwakura Y., Ishigame H. The IL-23/IL-17 axis in inflammation. J. Clin. Invest. 2006, 116:1218-1222.
20. Jo E.J., Lee H.Y., Lee Y.N., Kim J.I., Kang H.K., Park D.W., Baek S.H., Kwak J.Y., Bae Y.S. Group IB secretory phospholipase A2 stimulates CXC chemokine ligand 8 production via ERK and NF-kappa B in human neutrophils. J. Immunol. 2004, 173:6433-6439.
21. Johnson A.D., O'Donnell C.J. An open access database of genome-wide association results. BMC Med. Genet. 2009, 10:6.
22. Kaiser W.J., Upton J.W., Mocarski E.S. Receptor-interacting protein homotypic interaction motif-dependent control of NF-kappa B activation via the DNA-dependent activator of IFN regulatory factors. J. Immunol. 2008, 181:6427-6434.
23. Kim J., Basak J.M., Holtzman D.M. The role of apolipoprotein E in Alzheimer''s disease. Neuron 2009, 63:287-303.
24. Kojima M., Morisaki T., Izuhara K., Uchiyama A., Matsunari Y., Katano M., Tanaka M. Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-kappa B activation. Oncogene 2000, 19:1225-1231.
25. Lander E.S. Initial impact of the sequencing of the human genome. Nature 2011, 470:187-197.
26. Maffia P., Brewer J.M., Gracie J.A., Ianaro A., Leung B.P., Mitchell P.J., Smith K.M., McInnes I.B., Garside P. Inducing experimental arthritis and breaking self-tolerance to joint-specific antigens with trackable, ovalbumin-specific T cells. J. Immunol. 2004, 173:151-156.
27. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., McCarthy M.I., Ramos E.M., Cardon L.R., Chakravarti A., et al. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
28. Murakami M., Hirano T. A four step model for the IL-6 amplifier, a regulator of chronic inflammations in tissue-specific MHC class II-associated autoimmune diseases. Front. Immunol. 2011, 2:22.
29. Murakami M., Okuyama Y., Ogura H., Asano S., Arima Y., Tsuruoka M., Harada M., Kanamoto M., Sawa Y., Iwakura Y., et al. Local microbleeding facilitates IL-6- and IL-17-dependent arthritis in the absence of tissue antigen recognition by activated T cells. J. Exp. Med. 2011, 208:103-114.
30. Nishihara M., Ogura H., Ueda N., Tsuruoka M., Kitabayashi C., Tsuji F., Aono H., Ishihara K., Huseby E., Betz U.A., et al. IL-6-gp130-STAT3 in T cells directs the development of IL-17++ Th with a minimum effect on that of Treg in the steady state. Int. Immunol. 2007, 19:695-702.
31. Ogura H., Murakami M., Okuyama Y., Tsuruoka M., Kitabayashi C., Kanamoto M., Nishihara M., Iwakura Y., Hirano T. Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity 2008, 29:628-636.
32. Ohtani T., Ishihara K., Atsumi T., Nishida K., Kaneko Y., Miyata T., Itoh S., Narimatsu M., Maeda H., Fukada T., et al. Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses. Immunity 2000, 12:95-105.
33. O'Shea J.J., Ma A., Lipsky P. Cytokines and autoimmunity. Nat. Rev. Immunol. 2002, 2:37-45.
34. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005, 6:1133-1141.
35. Pickell L., Tran P., Leclerc D., Hiscott J., Rozen R. Regulatory studies of murine methylenetetrahydrofolate reductase reveal two major promoters and NF-kappaB sensitivity. Biochim. Biophys. Acta 2005, 1731:104-114.
36. Rojo A.I., Salinas M., Martín D., Perona R., Cuadrado A. Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-kappaB. J. Neurosci. 2004, 24:7324-7334.
37. Sakaguchi S., Sakaguchi N. Animal models of arthritis caused by systemic alteration of the immune system. Curr. Opin. Immunol. 2005, 17:589-594.
38. Sawa S., Kamimura D., Jin G.H., Morikawa H., Kamon H., Nishihara M., Ishihara K., Murakami M., Hirano T. Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4++ T cells. J. Exp. Med. 2006, 203:1459-1470.
39. Sawa Y., Arima Y., Ogura H., Kitabayashi C., Jiang J.J., Fukushima T., Kamimura D., Hirano T., Murakami M. Hepatic interleukin-7 expression regulates T cell responses. Immunity 2009, 30:447-457.
40. Schmitz T., Souil E., Hervé R., Nicco C., Batteux F., Germain G., Cabrol D., Evain-Brion D., Leroy M.J., Méhats C. PDE4 inhibition prevents preterm delivery induced by an intrauterine inflammation. J. Immunol. 2007, 178:1115-1121.
41. Sewell G.W., Marks D.J., Segal A.W. The immunopathogenesis of Crohn''s disease: a three-stage model. Curr. Opin. Immunol. 2009, 21:506-513.
42. Song Y.J., Jen K.Y., Soni V., Kieff E., Cahir-McFarland E. IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation. Proc. Natl. Acad. Sci. USA 2006, 103:2689-2694.
43. Thomas R.S., Tymms M.J., McKinlay L.H., Shannon M.F., Seth A., Kola I. ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter. Oncogene 1997, 14:2845-2855.
44. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
45. Wolf I., Pevzner V., Kaiser E., Bernhardt G., Claudio E., Siebenlist U., Förster R., Lipp M. Downstream activation of a TATA-less promoter by Oct-2, Bob1, and NF-kappaB directs expression of the homing receptor BLR1 to mature B cells. J. Biol. Chem. 1998, 273:28831-28836.
46. Yang J., Benyamin B., McEvoy B.P., Gordon S., Henders A.K., Nyholt D.R., Madden P.A., Heath A.C., Martin N.G., Montgomery G.W., et al. Common SNPs explain a large proportion of the heritability for human height. Nat. Genet. 2010, 42:565-569.
47. Zhang Y., Fujita N., Oh-hara T., Morinaga Y., Nakagawa T., Yamada M., Tsuruo T. Production of interleukin-11 in bone-derived endothelial cells and its role in the formation of osteolytic bone metastasis. Oncogene 1998, 16:693-703.